The implementation date of the highly anticipated 2025 Local Coverage Determinations (LCDs) for skin substitutes has been postponed until 4/13/2025, leaving providers and patients in a holding pattern. What does this delay really mean for your practice, and how do Medicare Administrative Contractors (MACs) historically approach such transitions?
Join us for an expert panel discussion featuring three distinguished speakers who will provide comprehensive insights into both current requirements and future changes.
Featured Speakers:
- Dr. Harry Feliciano, M.D., MPH, Former Senior Medical Director at Palmetto GBA and lead Contractor Medical Director for home health and hospice coverage policy
- Dr. Jeffrey Lehrman, DPM, nationally recognized certified professional coder and certified professional medical auditor
- Dr. Gunnar Johannsson, M.D., SVP of Health Policy & Medical Director at Kerecis
New Focus Points
MAC Perspectives on Coverage Transitions
-
- Historical approaches to coverage changes and LCD implementations
- Understanding how MACs interpret and apply “Reasonable and Necessary” criteria during transition periods
- Key insights from Dr. Feliciano’s experience in MAC coverage policy development
What to Expect From Medicare and the MACs During the Delay
-
- Will policies remain unchanged?
- How current MAC medical policies influence coverage decisions
- Practical implications for providers during the transition period
Advocating For or Against the LCD
-
- Understanding the MAC review process and effective advocacy strategies
- Why your input matters during the delay—and how providers, industry, and patients can make their voices heard
Preparing Your Practice Now
-
- Staying compliant under current rules
- Updating documentation protocols
- Planning for eventual LCD implementation
Continuing Core Topics
Coding Best Practices
-
- Proper use of modifiers, wastage documentation, and navigating CPT and HCPCS codes—especially in the Wound Care Center setting
Product-Specific Guidance
-
- Which Kerecis product can be applied over bone and tendon?
- How do you code for Kerecis Micro products?
- What if a patient has already received 8 skin substitutes from another provider?
Avoiding Common Pitfalls
-
- Practical strategies for compliance, minimizing denials, and maximizing patient access to quality care
Extended Q&A Session
- Your chance to ask our expert panel about MAC coverage policies, coding practices, and clinical applications
- Special focus on understanding historical MAC approaches to coverage transitions and implementation periods
Don’t miss this essential update on the current and future state of skin substitute coverage. Whether you’re looking for clarity on immediate coding practices or guidance on how to shape the LCD’s final form, this webinar provides the insights you need to stay ahead.
